• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Constellation Pharma

Graphic of three faceless profiles aimed diagonally to the right with two check marks in between them Orange background
Biotech

Third Rock adds 3 new venture partners, including Karuna’s Paul

The new hires and promotions at Third Rock include former executives at Karuna Therapeutics, Constellation and Beam.
Max Bayer Jan 25, 2024 10:35am
hand over keys buy house gift takeover acquisition

MorphoSys finds billion-dollar home for unwanted assets

Jun 15, 2022 4:00am
Monoclonal Antibody GettyImages

MorphoSys axes US R&D work following Constellation buy

Mar 10, 2022 1:31pm
Parachute

Magenta nabs Constellation CMO after 5-month search, trial snag

Oct 4, 2021 10:20am
MorphoSys

MorphoSys inks $1.7B Constellation buy, $1.4B financing deal

Jun 2, 2021 9:15am
stop sign knerri61Pixabay

FDA slaps partial hold on Epizyme’s lead drug

Apr 24, 2018 8:55am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings